Folic acid, vitamin B12, MTHFR genotypes, and plasma homocysteine

被引：7

作者：

Golledge, J ^{[1
]}

Jones, L ^{[1
]}

Oliver, L ^{[1
]}

Quigley, F ^{[1
]}

Karan, M ^{[1
]}

机构：

[1] James Cook Univ N Queensland, Vasc Biol Unit, Townsville, Qld 4811, Australia

来源：

CLINICAL CHEMISTRY | 2006年 / 52卷 / 06期

关键词：

D O I：

10.1373/clinchem.2006.069849

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1205 / 1206

页数：2

共 7 条

[1] Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials [J].

Clarke, R ;

Armitage, J ;

Lewington, S ;

Sherliker, P ;

Collins, R ;

Brown, M ;

Blackwood, S ;

Bostom, A ;

Loan, E ;

Yusuf, S ;

Genest, J ;

Bonaa, K ;

Njolstad, I ;

Mennen, L ;

Galan, P ;

Hercberg, S ;

Jamison, R ;

Gaziano, JM ;

Hartigan, P ;

Hankey, G ;

Eikelboom, J ;

Toole, J ;

Malinow, MR ;

Chambless, LE ;

Spence, JD ;

Pettigrew, L ;

Howard, VJ ;

Sides, EG ;

Wang, CH ;

Stampfer, M ;

Manson, JE ;

Nygard, O ;

Nordrehaug, JE ;

Nilsen, DWT ;

Refsum, H ;

Ueland, PM ;

Vollset, SE .

AMERICAN HEART JOURNAL, 2006, 151 (02) :282-287

[2] Efficacy of B vitamins in lowering homocysteine in older men -: Maximal effects for those with B12 deficiency and hyperhomocysteinemia [J].

Flicker, L ;

Vasikaran, SD ;

Thomas, J ;

Acres, JM ;

Norman, P ;

Jamrozik, K ;

Hankey, GJ ;

Almeida, OP .

STROKE, 2006, 37 (02) :547-549

[3] Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis [J].

Golledge, J ;

McCann, M ;

Mangan, S ;

Lam, A ;

Karan, M .

STROKE, 2004, 35 (07) :1636-1641

[4] Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes [J].

Pastore, A ;

De Angelis, S ;

Casciani, S ;

Ruggia, R ;

Di Giovamberardino, G ;

Noce, A ;

Splendiani, G ;

Cortese, C ;

Federici, G ;

Dessì, M .

CLINICAL CHEMISTRY, 2006, 52 (01) :145-148

[5] Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension [J].

Speirs, HJL ;

Katyk, K ;

Kumar, NN ;

Benjafield, AV ;

Wang, WYS ;

Morris, BJ .

JOURNAL OF HYPERTENSION, 2004, 22 (05) :931-936

[6] Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial [J].

Toole, JF ;

Malinow, MR ;

Chambless, LE ;

Spence, JD ;

Pettigrew, LC ;

Howard, VJ ;

Sides, EG ;

Wang, CH ;

Stampfer, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05) :565-575

[7] Serum homocysteine in relation to mortality and morbidity from coronary heart disease -: A 24-year follow-up of the Population Study of Women in Gothenburg [J].

Zylberstein, DE ;

Bengtsson, C ;

Björkelund, C ;

Landaas, S ;

Sundh, V ;

Thelle, D ;

Lissner, L .

CIRCULATION, 2004, 109 (05) :601-606

← 1 →